Shares of FibroGen jumped 5.79% to $20.09 at 15:14 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is falling 1% to $13,774.94, following last session’s downward trend, This seems, as yet, a somewhat negative trend exchanging session today.

FibroGen’s last close was $19.00, 184.77% below its 52-week high of $57.21.

The company’s growth estimates for the ongoing quarter and the next is 2.2% and 62.1%, respectively.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $20.09 at 15:14 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $18.77.

FibroGen’s Moving Average

FibroGen’s worth is way under its 50-day moving average of $39.14 and way under its 200-day moving average of $42.31.

More news about FibroGen.

LEAVE A REPLY

Please enter your comment!
Please enter your name here